NCT00195793View on ClinicalTrials.gov

A 16 Week Comparative Study of Fenofibrate Versus Ezetimibe as Add-on Therapy to Atorvastatin

PHASE3CompletedINTERVENTIONAL
Enrollment

174

Participants

Timeline

Start Date

August 31, 2004

Conditions
Hyperlipidemia
Interventions
DRUG

fenofibrate

DRUG

ezetimibe

DRUG

atorvastatin

Sponsors

Lead Sponsor

Abbott
All Listed Sponsors
lead

Abbott

INDUSTRY